title: Occurrence of double primary malignancies in an African renal transplant recipient.
abstract: A 63-year-old African male with end stage renal disease who received a renal transplantation from his daughter after successful treatment of hepatitis C virus, type 1 genotype developed metastatic Kaposi's sarcoma and subsequently adenocarcinoma of the prostate. He was successfully treated with chemotherapy and reduction of immunosuppression and switch over to rapamycin.
authors.forename: Pavithra
authors.initials: P
authors.lastname: Mohan
authors.forename: Anand
authors.initials: A
authors.lastname: Yuvaraj
authors.affiliation: Department of Nephrology, Madras Medical Mission, Chennai, Tamil Nadu, India.
authors.forename: Georgi
authors.initials: G
authors.lastname: Abraham
authors.forename: Abraham
authors.initials: A
authors.lastname: Kurien
authors.forename: Anila
authors.initials: A
authors.lastname: Abraham
authors.forename: Milly
authors.initials: M
authors.lastname: Mathew
authors.forename: S
authors.initials: S
authors.lastname: Saravanan
authors.forename: Sanjeev
authors.initials: S
authors.lastname: Nair
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D044383:Black People; D057915:Drug Substitution; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology* / Q000556:secondary; D020123:Sirolimus / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013636:Tanzania; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D020123:Sirolimus